Table 2.
Correlation of FAK and phospho-FAK expression with recurrence-free survival and overall survival in (A) NSCLC and (B) SCLC patients in a univariate analysis.
| A | ||||
|---|---|---|---|---|
| Variable | Recurrence-Free Survival | Overall Survival | ||
| HR (95% CI) | p-Value | HR (95% CI) | p-Value | |
| FAK staining score | 1.00 (1.00–1.00) | 0.92 | 1.00 (1.00–1.00) | 0.99 |
| Phospho-FAK staining score | 0.99 (0.98–1.00) | 0.1 | 0.99 (0.98–1.00) | 0.21 |
| Ratio phospho-FAK/FAK staining scores | 0.86 (0.60–1.23) | 0.33 | 0.89 (0.64–1.21) | 0.4 |
| B | ||||
| Variable | Recurrence-Free Survival | Overall Survival | ||
| HR (95% CI) | p -Value | HR (95% CI) | p -Value | |
| FAK staining score | 1.00 (1.00–1.00) | 0.76 | 1.00 (1.00–1.00) | 0.66 |
| Phospho-FAK staining score | 1.00 (1.00–1.01) | 0.5 | 1.00 (0.99–1.00) | 0.8 |
| 100 × ratio phospho-FAK/FAK staining scores | 0.96 (0.90–1.02) | 0.13 | 1.00 (0.97–1.03) | 0.75 |
Abbreviations: CI, confidence interval; FAK, focal adhesion kinase; HR, hazard ratio.